Strumento inattivo

Azioni Cornerstone Therapeutics, Inc.

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	28/02/14
Cornerstone Therapeutics Inc. Stockholders Approve Merger	03/02/14
Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	01/02/14
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	20/11/13
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	31/10/13

Settore

	Variaz. 1 gen.	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20,37%	43,54 Mrd
OTSUKA HOLDINGS CO., LTD.	+19,44%	21,78 Mrd
SANDOZ GROUP AG	+17,85%	15,38 Mrd
CIPLA LIMITED	+25,55%	15,12 Mrd
ZYDUS LIFESCIENCES LIMITED	+60,99%	13,36 Mrd
THE MEDICINES COMPANY	-0,05%	6,79 Mrd
ONO PHARMACEUTICAL CO., LTD.	-15,02%	6,38 Mrd
STADA ARZNEIMITTEL	-8,87%	5,73 Mrd
ASPEN PHARMACARE HOLDINGS LIMITED	+8,17%	5,32 Mrd